PLoS ONE (Jan 2012)

Epistasis analysis for estrogen metabolic and signaling pathway genes on young ischemic stroke patients.

  • Yi-Chen Hsieh,
  • Jiann-Shing Jeng,
  • Huey-Juan Lin,
  • Chaur-Jong Hu,
  • Chia-Chen Yu,
  • Li-Ming Lien,
  • Giia-Sheun Peng,
  • Chin-I Chen,
  • Sung-Chun Tang,
  • Nai-Fang Chi,
  • Hung-Pin Tseng,
  • Chang-Ming Chern,
  • Fang-I Hsieh,
  • Chyi-Huey Bai,
  • Yi-Rhu Chen,
  • Hung-Yi Chiou,
  • Formosa Stroke Genetic Consortium

DOI
https://doi.org/10.1371/journal.pone.0047773
Journal volume & issue
Vol. 7, no. 10
p. e47773

Abstract

Read online

BackgroundEndogenous estrogens play an important role in the overall cardiocirculatory system. However, there are no studies exploring the hormone metabolism and signaling pathway genes together on ischemic stroke, including sulfotransferase family 1E (SULT1E1), catechol-O-methyl-transferase (COMT), and estrogen receptor α (ESR1).MethodsA case-control study was conducted on 305 young ischemic stroke subjects aged ResultsCOMT Val158Met polymorphism showed a significant association with susceptibility of young ischemic stroke among females. There was a two-way interaction between SULT1E1 -64G/A and COMT Val158Met in both MDR and CART analysis. The logistic regression model also showed there was a significant interaction effect between SULT1E1 -64G/A and COMT Val158Met on ischemic stroke of the young (P for interaction = 0.0171). We further found that lower estradiol level could increase the risk of young ischemic stroke for those who carry either SULT1E1 or COMT risk genotypes, showing a significant interaction effect (P for interaction = 0.0174).ConclusionsOur findings support that a significant epistasis effect exists among estrogen metabolic and signaling pathway genes and gene-environment interactions on young ischemic stroke subjects.